The Thailand Department of Thai Traditional and Alternative Medicine (DTAM) is rolling out an electronic submission system for controlled herb exports that will slash processing times by up to 70%, a significant upgrade for cannabis businesses navigating the country's tightening regulatory framework. The new platform connects DTAM's internal "DTAM Next" system directly to the Thailand Customs Department's National Single Window (NSW), eliminating paper forms and in-person submissions that have slowed trade flows since medical cannabis exports began in earnest three years ago.
Why This Matters
• Processing speed: Export approval drops from 5-7 working days to 1-2 working days electronically.• Export volume: Thailand has shipped ฿2.56 billion worth of medical cannabis cumulatively, representing steady growth in the licensed export sector.• Compliance burden: Less than 2% of licensed cannabis operators currently meet the minimum GACP certification required for export, making streamlined procedures critical for the handful of compliant players.• Paper savings: The system will eliminate 1,200-2,400 physical documents annually, based on current monthly submission volumes of 100-200 forms.
From Paper to Pixels
Under the previous system, exporters were required to prepare and physically submit the Por Thor 32 (ภ.ท.32) form, the official declaration document for controlled herb shipments. Each submission involved travel to government offices, manual document review, and multi-day processing lags. The digital integration automates data transfer between DTAM and Customs, improving accuracy and reducing the risk of document forgery that has plagued manual systems.
The upgrade arrives as the Thailand Food and Drug Administration (FDA) and the Office of the Narcotics Control Board (ONCB) continue to issue export licenses under a patchwork of ministerial regulations. Thailand still lacks a unified Cannabis and Hemp Act, which remains stalled in parliament. Until that legislation passes, exporters must navigate overlapping requirements from three separate agencies—DTAM, the FDA, and the ONCB—each with distinct documentation standards.
What This Means for Exporters
For GACP-certified farms capable of legal export, the digital platform represents a material cost reduction. Exporters will no longer need to dispatch staff to government offices or courier physical documents, cutting both time and logistics expenses. The system also provides real-time shipment tracking, a feature that importers in Australia, Germany, Japan, and the United Kingdom—the primary buyers of Thai medical cannabis—have increasingly demanded for supply chain transparency.
However, the streamlined submission process does not alter the underlying compliance requirements. Exporters must still maintain Good Agricultural and Collection Practice (GACP) certification, which mandates rigorous record-keeping, seed-to-sale traceability, and adherence to pharmaceutical-grade safety standards. Industry observers expect further consolidation as operators unable to meet compliance standards exit the market.
Policy Context: Medical-Only Framework
The digital platform launch follows Thailand's reclassification of cannabis flowers as a controlled herb, which effectively ended the experimental decriminalization period that began in June 2022. Since the re-criminalization, cannabis can only be sold with a medical prescription, and dispensaries must employ certified medical practitioners on-site. Online sales are prohibited. The policy shift has narrowed the domestic market but clarified the regulatory pathway for export-focused businesses, which were already operating under medical-use-only licensing.
The Thailand government's focus has shifted decisively toward high-compliance, high-value medical cannabis exports rather than mass-market domestic consumption. Recent regulations imposed traceability requirements on all cannabis flower exports, requiring operators to deploy seed-to-sale software platforms like Cantrak to track every stage from cultivation to shipment. These systems generate the audit trails needed for FDA reporting and ONCB documentation.
Export Market and Regional Position
Thailand has established itself as a credible supplier in Southeast Asia's regulated medical cannabis sector. The export market benefits from Thailand's tropical climate, which supports year-round production, and from the regulatory advantages of having an established licensing framework. Export growth is constrained not by cultivation capacity but by compliance certification. GACP audits require meticulous documentation of soil inputs, irrigation schedules, pest management, and post-harvest handling, a level of rigor that small-scale operators have struggled to meet. Purpose-built compliance software and third-party audits add significant upfront costs, creating a barrier to entry that favors larger, better-capitalized farms.
Globally, Thai exporters compete with established medical cannabis producers in Canada, Uruguay, and Israel, which have more mature regulatory frameworks and longer-established pharmaceutical cannabis industries. Thai exporters are positioning themselves in the high-compliance, high-value segment rather than competing on volume.
Destination Requirements and Traceability
Export approvals depend not only on Thai compliance but also on destination country regulations. Shipments to the European Union require Phytosanitary certificates and adherence to EU Good Manufacturing Practice (GMP) standards. Australia mandates separate import licenses issued by the Therapeutic Goods Administration (TGA), which conducts its own quality audits. Japan restricts imports to CBD isolates and specific pharmaceutical formulations, excluding full-spectrum cannabis products.
The DTAM Next–NSW integration simplifies the Thai side of the process but does not replace the need for destination-country documentation. Exporters must still coordinate with foreign regulatory bodies, a process that can add weeks to shipment timelines. The digital platform's shipment tracking feature allows Thai exporters to provide real-time status updates to foreign importers, improving communication and reducing the risk of missed delivery windows.
Looking Ahead
The digital export platform represents incremental progress rather than a fundamental overhaul. The Thailand parliament has yet to pass the comprehensive Cannabis and Hemp Act that would establish a single licensing authority and unified export standards. Until that legislation advances, exporters will continue navigating a fragmented regulatory environment, albeit with faster document processing.
For GACP-certified farms currently eligible to export, the new system offers immediate operational benefits. For remaining licensed operators, the platform highlights the compliance gap that separates domestic cultivation from international trade. As licensing requirements tighten, the export sector is likely to consolidate around operators capable of meeting pharmaceutical-grade standards and absorbing the costs of digital traceability systems.
The Thai government's willingness to invest in digital infrastructure signals continued support for medical cannabis exports, even as domestic policy remains tightly regulated. The platform ensures that compliant exporters can move product quickly—provided they can navigate the licensing requirements that remain in place until parliament passes comprehensive cannabis legislation.
